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Background: Caveolin-1 (CAV1) may be upregulated by hypoxia and acts in a tumor-dependent manner. We
investigated CAV1 in tongue squamous cell carcinoma (TSCC) and its association with clinical outcomes, and
studied in vitro possible ways for CAV1 accumulation in the tumor microenvironment (TME).
Methods: TSCC cases (N = 64) were immunohistochemically stained for CAV1. Scores were separately assessed in
the tumor and TME and plotted for association with recurrence and survival (univariate analysis with log-rank test).
In vitro studies were performed on a 3D myoma organotypic model, a mimicker of TME. Prior to monoculturing
HSC-3 tongue cancer cells, the model underwent modifications in oxygenation level (1%O2 hypoxia to upregulate
CAV1) and/or in the amount of natural soluble factors [deleted by 14-day rinsing (rinsed myoma, RM), to allow only
HSC-3-derived factors to act]. Controls included normoxia (21%O2) and naturally occurring soluble factors (intact
myoma, IM). HSC-3 cells were also co-cultured with CaDEC12 cells (fibroblasts exposed to human tongue cancer).
CAV1 expression and cellular distribution were examined in different cellular components in hypoxic and rinsed
myoma assays. Twist served as a marker for the process of epithelial-mesenchymal transition (EMT). Exosomes
isolated from HSC-3 media were investigated for containing CAV1.
Results: Expression of CAV1 in TSCC had a higher score in TME than in the tumor cells and a negative impact on
recurrence (p = 0.01) and survival (p = 0.003). Monocultures of HSC-3 revealed expression of CAV1 mainly in the
TME-like myoma assay, similar to TSCC. CAV1+, alpha-smooth muscle actin (αSMA) + and Twist + CAF-like cells were
observed surrounding the invading HSC-3, possibly reflecting EMT. RM findings were similar to IM, inferring action
of HSC-3 derived factors, and no differences were seen when hypoxia was induced. HSC-3-CaDEC12 co-cultures
revealed CAV1+, αSMA+ and cytokeratin-negative CAF-like cells, raising the possibility of CaDEC12 cells gaining a
CAF phenotype. HSC-3-derived exosomes were loaded with CAV1.
Conclusions: Accumulation of CAV1-TME in TSCC had a negative prognostic value. In vitro studies showed the
presence of CAV1 in cancer cells undergoing EMT and in fibroblasts undergoing trans-differentiation to CAFs.
CAV1 delivery to the TME involved cancer cell-derived exosomes.
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A growing body of evidence has emerged in the last dec-
ade supporting the important role of the tumor micro-
environment (TME) and its components in oral cancer
growth, invasion and spread, especially in tongue cancer,
the most frequent and aggressive type of oral cancer [1,2].
These biological features are most likely influenced by the
molecular crosstalk between the cancer cells and various
TME components, such as cancer-associated fibroblasts
(CAFs) [3], inflammatory cells [3,4] and mesenchymal
stem cells [5], hypoxic conditions, angiogenesis and extra-
cellular matrix modulation. One of the factors involved in
the molecular crosstalk are the exosomes, which are
nano-vesicles secreted by the cancer cells [6,7]. Exosomes,
which are now considered as one of the major intercellular
communication vehicles, are able to transfer proteins and
genetic material to other cells and to the extracellular
matrix [8,9]. We have recently shown in vitro the presence
of exosomal markers in both oral tongue cancer cells and
within TME components [3].
Caveolin-1 (CAV1) is expressed in most cell types [10]
and is present in a variety of cellular and extracellular
compartments, thus explaining the variability of its func-
tions and multiple interactions with signaling proteins
that shape the outcome of its actions [11-14]. CAV1 has
a role in both normal tissue homeostasis and patho-
logical conditions, where it has been shown in some
studies to be upregulated by the hypoxia-inducible factor
(HIF)-α [13,14]. A crisis in oxygen availability or a tumor
exhibiting a hypoxic signature leads to HIF-α–dependent
up-regulation of CAV1 that enhances the oncogenic po-
tential of tumor cells by increasing the cell’s proliferative,
migratory, and invasive capacities [14]. It has recently
been shown that the stroma of several human carcin-
omas, such as breast, colorectal and kidney, as well as
that of metastatic melanomas, is enriched in CAV1-
expressing CAFs. Furthermore, CAV1 expression in the
CAFs of breast cancer correlated with low survival [13].
Most studies on CAV1 in oral squamous cell carcin-
oma (OSCC) examined its expression in the process of
carcinogenesis. Clinico-pathological studies showed an
increased immunoexpression of CAV1 in SCC tissue
when compared to normal mucosa and precancerous
(dysplastic) lesions [15]. Furthermore, quantum-dot immu-
nohistochemistry in tissue microarrays showed an in-
creased expression of CAV1 in stepwise carcinogenesis,
from normal tongue mucosa, through hyperplasia, through
precancerous lesions, and finally to primary SCC [16]. In
addition, genetic studies on cell and tissue cultures as well
as on human samples showed an increase in CAV1 gene
expression in malignant cells compared to normal cells
[17,18]. The aim of our study was to investigate the differ-
ential expression of CAV1 in cancer cells and in the TME
of tongue SCC (TSCC) and to determine possibleassociations with clinical outcome. We monocultured a cell
line of TSCC cells, HSC-3, on the 3D myoma organotypic
model, considered as a best mimicker of TME due to the
facts that the composition and variability of the soluble fac-
tors, the presence of various extracellular matrix proteins
and glycoproteins as well as an inbuilt hypoxic environ-
ment enable cultured cancer cells to better manifest their
malignant potential compared with collagen organotypic
cultures [2,19,20]. Since the myoma discs by themselves
lacked expression of CAV1, the notable expression of
CAV1 in the cultures could be linked to HSC-3 delivery of
CAV1 concomitant with the development of hypoxic con-
ditions. In addition, we co-cultured HSC-3 cells with nor-
mal human gingival fibroblasts and a cell line of tongue
cancer-related fibroblasts (CaDEC12 cells) in an attempt to
highlight the co-expression of CAV1and αSMA in spin-
dle cells surrounding the tumor islands and to deter-
mine any possible involvement of CAV1 in both
epithelial-mesenchymal transition and fibroblast-to-
cancer-associated fibroblast (CAF) trans-differentiation
processes. Finally, we performed studies on monolayers
of HSC-3 with the aim of determining whether the de-
livery of CAV1 from the HSC-3 cells into the TME was
mediated by exosomes.
Methods
Expression of CAV1 in tongue carcinoma patients and
association with clinical outcome
The study was approved by the IRB of the Chaim Sheba
Medical Center (SMC 8437–11), Tel Hashomer, Israel.
Accordingly, patient records/information was anon-
ymized and de-identified prior to analysis. The study in-
cluded tongue cancer patients (n = 64) diagnosed and
treated between 1990 and 2006. They were comprised of
31 females (mean age 65 ± 11.7 years) and 33 males
(mean age 57.4 ± 17.9 years), and classified as being in
early-stage (stages I and II, n = 15) and late-stage (stages
III and IV, n = 49) disease. The detailed clinical data on
treatment and follow-up have been presented in detail in
our previous study [3]. The clinical outcomes were mea-
sured by time to locoregional recurrence (LR) at the pri-
mary tumor site/cervical metastases/both and by overall
survival (OS) of patients who were alive and free of disease/
with disease at the last follow-up visit. The survival analysis
included only patients followed-up for ≥18 months (n = 54).
Sections were prepared from paraffin blocks and im-
munostained with CAV1 (E294, Abcam, Cambridge,
UK) according to the manufacturer’s instructions. Cyto-
plasmic expression of CAV1 was observed in the TME
components (i.e., endothelial cells, CAFs, inflammatory
cells). Since it was not possible to separate those compo-
nents, the CAV1 expression in the TME was collectively
termed “CAV-TME”. CAV1 expression in the tumor
cells was termed “CAV-SCC”. The scores for CAV-TME
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manner by considering the intensity of the staining (0 =
no expression, 1 = weak expression, 2 =moderate expres-
sion, and 3 = strong expression) multiplied by the % of
positive cells, with a maximum score of 3. In addition,
the total CAV score in each case was determined as the
sum of the CAV-TME plus the CAV-SCC scores. For
statistical purposes, all the scores (i.e., TME, SCC and
total) were classified as being low (score ≤median) or
high (score > median). Specimens of human placenta
were used as positive control, and elimination of the pri-
mary antibody served as the negative control.
Data analysis
For the CAV-stained patient tongue samples, univariate
analysis was performed using the Kaplan–Meier method,
and significance was confirmed by the log-rank test
(SPSS, version 15, SPSS Inc., Chicago, IL, USA). Signifi-
cance was set at P < 0.05.Tongue cancer cells – In vitro studies
HSC-3 cells mono- and Co-cultures using the 3D organotypic
myoma model
This study was approved by the Ethics Committee of the
Oulu University Hospital, Oulu, Finland.
The 3D organotypic myoma model was based on uter-
ine leiomyoma tissue that was obtained from routine
surgical operations after informed consent of the donors.
The model was previously described in detail [19].
Homogeneous areas of the myoma served as sources for
preparing discs for the organotypic culture by first cut-
ting 3-mm slices with a disposable scalpel and further
into discs with an 8-mm biopsy punch (Kai Industries
Co., Gifu, Japan). The myoma discs were stored at −70°C
in media with 10% DMSO (Sigma Aldrich). For prepar-
ing myoma-based organotypic cultures, myoma discs
were equilibrated in media at room temperature (RT)
for 1 hour. The myoma discs were placed into Transwell
inserts (diameter, 6.5 mm; Corning, Inc., Corning, NY).
For preparing mono-cultures, 3–4 × 105 cells (e.g., oral
tongue SCC HSC-3 cells, Japanese Collection of Re-
search Bioresources Cell Bank, Japan) were cultured on
the top of myoma tissue and allowed to attach overnight,
and the myoma discs were removed from the Transwell
inserts and transferred onto uncoated nylon discs resting
on curved steel grids (3 × 12 × 15 mm) in 12-well plates
with sufficient volume of media (1 ml). The myoma orga-
notypic cultures were maintained for 14 days, and the
media were changed according to the collagen organotypic
culture protocol. In the co-culture assays, 2–3 × 105 cancer
cells were first mixed with 4 × 105 other cell types (e.g., fi-
broblasts) and then cultured on myoma tissue and further
processed as the mono-cultures [3,19].In addition, rinsed myoma (RM) discs were prepared
by rinsing discs in DMEM (Sigma Aldrich, Ayrshire,
UK), gently rotating them at 4°C for two weeks and
changing the media every three days [20]. The culturing
procedures on the RM discs were identical to the above-
described methodology.
Experiments were performed in normoxic and two
types of hypoxic conditions: (a) 1% O2 hypoxia created
by exposure of the assays in a hypoxic chamber (InVivo2
400, Ruskinn Technology, UK) for 20 h, and (b) overnight
exposure to 100 mM cobalt chloride (CoCl2), a known
hypoxia-mimicker, according to Brusewold et al. [21] and
detailed elsewhere [20]. More specifically, HSC-3 mono-
cultures were performed on both intact myoma (IM) and
RM discs in both normoxic and hypoxic conditions. Co-
cultures were performed on IM discs in normoxia.
Determining CAV1 expression in IM and RM discs
The IM and RM discs were snap-frozen in liquid nitro-
gen, crushed to a fine powder, dissolved in elution buffer
overnight, and centrifuged (13,000 × g, 10 min), and the
supernatant was collected and further prepared for
Western blotting [20]. Briefly, the supernatant was re-
suspended in 1x RIPA buffer, followed by Laemmli buffer.
Proteins (14–20 μg/well) were separated by electrophor-
esis with 12% sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE). Overnight incubation with
monoclonal rabbit CAV-1 antibody (1:5,000, clone E249,
Abcam, Cambride, UK) was followed by a 1-h incubation
with biotinylated polyclonal swine anti-rabbit secondary
antibody (1:1000, Dako, Glostrup, Denmark). Membranes
were developed with Pierce ECL Western blotting
substrate.
HSC-3 organotypic mono-cultures and immunohisto-
chemical stains The RM discs that had been mono-
cultured with HSC-3 (3–4 × 105 cells) at 37°C with 5%
CO2 for 14 days [3,20] were studied for the immunohis-
tochemical expression of CAV1 and αSMA (serial sec-
tions). The same mono-cultures were also performed on
the IM followed by the same immunostaining. RM/IM
discs were fixed in 4% neutral-buffered formalin and em-
bedded in paraffin [3,20]. Five micron-thick sections were
immunostained with anti-caveolin-1 (E294, rabbit mono-
clonal, Abcam, Cambridge, UK, 1:250) or with anti-αSMA
(1A4, mouse monoclonal, Dako, Glostrup, Denmark,
1:1000). Staining was demonstrated by a Dako REAL En-
Vision kit (peroxidase/DAB+, Dako) for mouse and rabbit
primary antibodies. The above-described procedures on
RM and IM HSC-3 mono-cultures were performed in
both normoxic and hypoxic (1%O2) conditions [20].
IM and RM HSC-3 mono-cultures in normoxic and
hypoxic conditions were triple immunostained with
CAV1 antibody (1:100), pan-cytokeratin (1:50) and Twist
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equal volumes of CAV1 and cytokeratin antibodies was
incubated overnight at 4°C, rinsed and added to double-
stain polymer adjusted for both mouse (HRP) and rabbit
(AP) antibodies (Innovex Biosciences, Pinoles, CA, USA)
for 30 min at RT. Sections were then stained with DAB
for visualizing cytokeratin colored brown and with fast
red (Permanent AP red kit, Zytomed, Berlin, Germany)
for visualizing CAV1 colored purple. Antigen retrieval
for Twist was performed by heating the slides in sterile
water at 92° for 10 min and cooling for 20 min, followed
by exposure to the Twist antibody at 4°C overnight and
thereafter conjugation with rabbit/mouse polymer (Super-
picture HRP, Invitrogen, Frederick, MD, USA) for
30 min at RT. Twist was finally visualized colored green
(Permanent HRP green kit, Zytomed, Berlin, Germany).
The other series of triple immunostaining comprised
cytokeratin (colored brown), Twist (colored purple) and
alpha-smooth muscle actin (αSMA, colored green; 1:50;
1A4, Dako, Glostrup, Denmark). The procedure started
with the mixing of equal volumes of Twist and cytokera-
tin antibodies followed by αSMA.
Assessment of the triple-immunostained sections
was only qualitative and intended to demonstrate the
localization of the staining among the cell types. Since
the triple immunostaining revealed a similar pattern of
expression of CAV1 in both RM and IM assays in nor-
moxic and hypoxic conditions, the co-culture studies
were performed only on the IM discs in normoxic
conditions.
Co-cultures of HSC-3 with gingival fibroblasts and
CaDEC12 cells on top of myoma discs HSC-3 cells
were co-cultured with human gingival fibroblasts (GFs,
obtained from biopsies of healthy gingiva) [19] or with
CaDEC12 cells (supplied by DEC) [3,5]. The latter are fi-
broblasts isolated from the connective tissue near tongue
carcinoma. These cells were characterized at passage 3
for the expression of lineage-specific markers by flow cy-
tometry and immunohistochemistry. They expressed the
fibroblast markers vimentin (98.67% positive cells) and
platelet-derived growth factor receptor (PDGFR)-B (97.60%
cells), and were negative for epithelial (epidermal surface
antigen [ESA] 0.09% positive cells), endothelial (CD31
0.65% positive cells), and hematopoietic (CD45 0.25% posi-
tive cells) lineage-specific markers. They were also
negative for αSMA. Very low levels of the pericyte/mes-
enchymal stem cell marker CD146 (1.48% positive cells)
were detected. In addition, p53 (exons 5–9) mutation
analysis was performed using genomic DNA, and it re-
vealed that CaDEC12 fibroblastic cells were harboring
wt p53, while the epithelial cells that had been derived
from the same tumor showed a p53 mutation in exon 7
(codon 772 G > A) [3,20].In the co-culture assays, 2–3 × 105 HSC-3 cells were
first mixed with 4 × 105 GFs or CaDEC12 cells and then
cultured on myoma discs [3]. The immunostaining pro-
cedures and the assessment of CAV1and αSMA in the
co-culture assays were done as described above. In
addition, sections from the co-cultures were submitted
to double immunostaining with CAV1, colored brown,
and pan-cytokeratin (AE1/AE3, Dako, 1:200, 30 min
RT), colored grey, using the SG color chart (Vector
Laboratories, Burlingame, CA, USA). Furthermore, some
of the co-cultures were stained with αSMA, as described
above.
Assessment of CAV1 expression in the co-cultures was
performed semi-quantitatively on a scale of 0 to 4: 0 = no
staining, 1 = weak staining in <50% cells, 2 = weak but ex-
tensive (>50% cells) staining, 3 = strong staining in <50%
cells, and 4 = strong staining in >50% cells, as previously
described [3]. The HSC-3 and the cells immediately sur-
rounding or adjacent to the tumor islands/clusters were
assessed separately for the upper region of the section (the
area of the lining tumor cells and the adjacent sub-
tumoral stroma) and in the lower region (the area of in-
vading tumor islands and the surrounding cells). This
semi-quantitative assessment attempted to give a general
overview of the staining patterns and, as such, was not fur-
ther processed by statistical analysis. Sections of HSC-3
monocultures immunostained with CAV1 served as con-
trols. Assessment of αSMA was qualitative and intended
to show the presence and distribution of spindle-shaped,
positively stained cells and their relations to the tumor
islands/clusters.
HSC-3 monolayer cultures
Similarly to the myoma assays, HSC-3 monolayers were
cultured in normoxic and in hypoxic (1% O2) and
hypoxia-mimicking (CoCl2) conditions.
CAV1 expression in HSC-3 cell extracts
Cell extracts were processed for Western blotting, as de-
scribed above. The same procedure for CAV1 blotting was
performed on cell media after centrifugation at 3000 × g
for 15 min to remove cell debris.
HSC-3 cell-media exosome isolation
HSC-3 monolayers were grown in normoxia in DMEM/
F12-medium supplied with 10% fetal bovine serum (both
from Life Technologies, Carlsbad, CA, USA), 50 μg/ml
ascorbic acid, 0.4 μg/ml hydrocortisone, 100 U/ml peni-
cillin, 100 μg/ml streptomycin and 250 ng/ml Fungizone
(all from Sigma Aldrich) until 90% confluence. The cells
were then washed with PBS, and incubation continued
in Opti-MEM® I Reduced Serum Medium (Life Tech-
nologies) for 24 h. One bottle of 15 × 106 HSC-3 cells
was similarly treated and incubated with Opti-MEM
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ate (APMA, Sigma Aldrich, St. Louis, MO, USA) to in-
duce exosome release, as shown previously [22].
Incubation lasted for 6 h, after which the media were
collected and the exosomes were isolated with ExoQuick-
TC™ kit (Systems Biosciences, CA, USA) according to the
manufacturer’s instructions. Briefly, the medium was cen-
trifuged at 3000 × g for 15 min to remove cell debris.
ExoQuick-TC solution was added to the supernatant in
a 5:1 ratio and kept at +4°C overnight. The solution was
then centrifuged 1500 × g for 30 min and the super-
natant was removed. The precipitate was suspended in
100–200 μl of PBS for ELISA and immuno-electron
microscopy (immunoEM) or 1 × RIPA-buffer for
Western blotting.
ELISA of the Exoquick-isolated exosomes ELISA ana-
lyses were performed for the identification of the exosomal
markers, CD63, CD9 and CD81 using the ExoELISA™ kits
(System BioSciences, CA, USA) according to the manufac-
turer’s instructions. After overnight incubation at 37°C,
CD63, CD9 or CD81 antibodies were added to the wells
(one antibody/well) and incubated for 1 h at RT, followed
by horseradish peroxidase-linked secondary antibody for
1 h at RT. TMB ELISA substrate was added, incubated for
30 min at RT and stop solution was added to end the reac-
tion. The amount of proteins was determined by read-
ing the optical density using a Victor 3 microplate
reader (Perkin Elmer, MA, USA) at 450 nm. The
amount of exosomal proteins was plotted against the
standard curves.
ELISA for determining CAV1 was performed using a
human CAV1 ELISA kit (MyBioSource, Inc., CA, USA)
according to the manufacturer’s instructions. Briefly,
50 μl of the PBS-suspended exosomal precipitates or
CAV1 standards were added to the antibody pre-coated
microtiter plate. Five μl of balance solution was added to
each well followed by 100 μl of conjugate. Incubation
continued for 1 h at 37°C. Substrates A and B were
added to each well, and incubation continued for 15 min
at 37°C. Stop solution was used to end the reaction, and
optical density was determined at 450 nm.
Western blotting of CAV1 in Exoquick-isolated exo-
somes Laemmli buffer with 2-mercaptoethanol was
added to the exosome pellets, followed by incubation in
boiling water. The subsequent procedures were the same
as those detailed above.
ImmunoEM of Exoquick-isolated exosomes The
precipitates were laid on Formvar carbon-coated,
glow-discharged grids for the immunoEM of the
Exoquick-isolated exosomes. The grids were first incu-
bated in a blocking serum containing 1% BSA in PBS.Antibodies and gold conjugates were diluted in 1%
BSA in PBS. The grids were then incubated with mouse
CD63 primary antibody (Abcam, Cambridge, UK) or
with CAV1 (Abcam, Cambridge, UK) for 20 min,
followed by rabbit anti-mouse IgG-gold with a particle
size of 10 nm (Aurion, Wageningen, The Netherlands)
for 20 min. The controls were prepared by replacing
the primary antibody with PBS. The grids were stained
with neutral uranyl acetate and embedded in methyl-
cellulose/uranyl acetate and examined with a Tecnai
Spirit transmission electron microscope (FEI, Eindhoven,
The Netherlands). Images were captured by a Quemesa
CCD camera (Olympus Soft Imaging Solutions GMBH,
Munster, Germany).
Results
Tongue cancer patients
The present study is the first to investigate the accumu-
lation of CAV1 in cancer cells and TME components in
a series of tongue cancer cases and its association with
clinical outcome. CAV-SCC was positive in all 64 cases
(median score 0.9, range 0.1–3), with only 11 cases being
greater than the median and only one case with a score
of 3. CAV-TME was positive in 54 cases (median 0.6,
range 0–3), with 24 cases being greater than the median
and 11 cases having a score of 3. CAV-total had a me-
dian of 1.6 (range 0.1–4.5). Figure 1A-C illustrates the
CAV1 staining patterns. Univariate analysis demon-
strated that only CAV-TME was associated with clinical
outcome: a high score had a negative impact on both re-
currence (P = 0.01) and survival (P = 0.003) (Figure 1D
and E, respectively). Although we detected evidence of
CAV1 in the tumor cells in all the examined cases, as re-
ported in previous studies [15-18], we found no significant
association with either recurrence or survival. These find-
ings motivated us to perform a series of in vitro studies in
which we attempted to determine the mechanisms of
CAV1 accumulation within the TME.
As mentioned in “Methods”, section on tongue cancer
patients, the present tumors were previously examined
for abundance of CAFs and the profile of the inflamma-
tory cells [3]. CAV-TME was found to be positively cor-
related with CAF density (r = 0.497, p < 0.001).
In vitro studies
Myoma organotypic model
Rinsed and intact myoma discs (RM and IM,
respectively): CAV1 expression Although cells within
the myoma discs are no longer expected to be viable
[19], the microenvironment is rich in soluble factors
with necessary functions for facilitating tumor growth
and invasion. Depletion of these factors (including
CAV1) by rinsing the myoma discs approached a state in
which factors released into the myoma assay originated
Figure 1 Caveolin-1 immunostaining patterns in human tongue sections and association with clinical outcomes. A. Staining in the tumor
is principally limited to the peripheral cells and is assessed with a score of 1.0 (50% for extent of staining and 2 for staining intensity). In contrast,
there is almost no staining of the tumor microenvironment (TME) that was given a score of 0.1 (10% for extent of staining and 1 for staining
intensity). B. Most of the tumor cells are strongly positive (a score of 3) and TME is negative (a score of 0). C. Caveolin-1 is moderately positive in
the tumor cells (score of 0.9), but it predominates in the TME (score of 3) (A, B, C - bar = 200 μ). D. Kaplan-Meyer analysis shows a significantly
negative influence of high CAV-TME score on locoregional recurrence (p = 0.01). E. Kaplan-Meier analysis shows a significantly negative influence
of high CAV-TME score on overall survival (p = 0.003).
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ther RM or IM discs showed no monomeric 21 kDa
form of CAV1 but only complex forms of immunoreac-
tants (Figure 2A). Thus, it can be inferred that CAV1 in
the myoma model is expected to originate from the cell
lines cultured in this assay.
HSC-3 monocultures in hypoxic and normoxic
conditions: CAV1 and αSMA expression Since ex-
pression of CAV1 is upregulated in hypoxic conditions
[13,14], mono-cultures were submitted to both hypoxia
and normoxia. We were interested in determining
whether growing the HSC-3 cells on the myoma discs in
different oxygenation conditions could have an effect on
the intra- or extracellular distribution of CAV1. Although
we found no CAV1 protein product in either the RM or
IM discs, we were interested in exploring any possibledifferences in the pattern of expression of CAV1 between
the two types of normoxic and hypoxic monocultures.
It was interesting to note that in all the monoculture as-
says, CAV1 was immunohistochemically identified mainly
in the “TME” cells, represented by the myoma discs, and
to a considerable lesser extent within the HSC-3 cells. In
the normoxic RM monocultures (devoid of myoma-
related mediators), CAV1-positive cells were present in
delicate, spindle-shaped cells concentrically surrounding
the periphery of the invading HSC-3 islands (Figure 2B).
This pattern of CAV1 expression and cellular distribution
was similar to that observed in the IM sections, therefore
it can be assumed that evolvement of the spindle cells and
their peri-tumoral organization were probably mediated
through signals originating from the HSC-3 cells. In
addition, since the same changes were seen in both nor-
moxic and hypoxic conditions, it is proposed that hypoxia
Figure 2 Caveolin-1 expression in HSC-3 cell myoma monocultures. A. Western blotting: caveolin-1 is detected as complex forms in intact
myoma (IM) tissue disc extracts (without added cells), and, to a lesser degree, in the rinsed myoma (RM, without added cells and without soluble
factors) disc extracts. Monomeric caveolin-1 is absent from both IM and RM tissue extracts. B. HSC-3 monocultures within rinsed myoma (RM) in
both normoxic and hypoxic conditions (a, b) show delicate, spindle, caveolin-1-positive cells closely surrounding invading HSC-3 islands. Alpha-smooth
muscle actin immunostaining in normoxic and hypoxic conditions (c, d) shows findings similar to caveolin-1 in terms of cell distribution and morphology.
HSC-3 monocultures within intact myoma (IM) immunostained with caveolin-1 (e, f) and alpha-smooth muscle (g, h) show findings similar to those of the
RM, respectively. CAV1 and alpha-smooth muscle actin positively stain the spindle cells surrounding the invading HSC-3 tumor islands (indicated by arrows).
In all sections, the HSC-3 cells are only occasionally CAV1-positive in both RM and IM, and in both normoxia and hypoxia. However, the spindle cells are
usually CAV1-positive, showing a high staining intensity.
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myoma model is characterized by an in-built potential for
a hypoxic environment [20]. Furthermore, we performed
αSMA immunostaining since the peri-tumoral location of
the CAV1-positive spindle cells recapitulated the arrange-
ment of CAFs in the human tongue SCC case. We found
that αSMA-positive spindle-shaped cells were also
present in RM and IM in both norrmoxic and hypoxic
conditions in distributions that were almost identical to
those of CAV1-positive cells (Figure 2B). Sections from
CoCl2 hypoxia-mimicking conditions in RM and IM as-
says were similarly stained and yielded comparable re-
sults (data not shown).
In malignant epithelial cells, factors, such as peroxi-
some proliferator-activated receptor-χ, are responsible
for an increased expression of CAV1 [23]. In contrast,
we found that CAV1 expression was higher in the TME-
like myoma than in HSC-3 cells in the monoculture as-
says, and we therefore inferred that CAV1 was exported
from the HSC-3 cells into the TME and assumed that
this was performed through the exosomal route, which
will be further described in the monolayer assays.HSC-3 monocultures in hypoxic and normoxic condi-
tions: triple immunostains Since in the previously de-
scribed experiment (i.e., IM and RM HSC-3 monocultures
in normoxic and hypoxic conditions) the CAV1-positive
spindle-shaped cells were found in an intimate relation to
the HSC-3 tumor clusters, we raised the possibility that the
origin of these cells could be from HSC-3 cells that had
undergone a process of epithelial-mesenchymal transition
(EMT). Therefore, serial sections from that experiment
were triple immunostained with CAV1, pan-cytokeratin
and Twist, an EMT marker. We found that invading
cytokeratin-positive HSC-3 cells in normoxic RM sec-
tions had a nuclear expression of Twist, and that a
number of cells also showed cytoplasmic expression of
CAV1 (Figure 3). The delicate spindle-shaped cells that
were concentrically arranged in the closest periphery of
the HSC-3 cells were CAV1-positive. This configuration
of the spindle cells was identified exclusively at the per-
iphery of invading HSC-3 cells and not in areas of my-
oma beyond this vicinity or in areas of myoma devoid of
HSC-3 cells. These findings were similar to those of
hypoxic RM sections, thus once more supporting the
Figure 3 HSC-3 monocultures with two types of triple immunohistochemical panels. Caveolin-1 (CAV1), Twist and cytokeratin (CK) in rinsed
and intact myoma in normoxia and hypoxia [cobalt chloride (CoCl2) or in hypoxia chamber with 1% O2)] (a-f) show similar patterns of expression
in all settings: positive nuclear staining of the invading HSC-3 islands with Twist (most nuclei) and diffuse cytoplasmic staining with cytokeratin
and, to a lesser extent, with CAV1 (arrows). In addition, delicate, spindle-shaped cells that closely surround these invading tumor islands in a
concentric pattern are also CAV1-positive. CK and alpha-smooth muscle actin (αSMA) in rinsed and intact myoma in normoxia and hypoxia [cobalt
chloride (CoCl2) or 1%O2)] (g-l) show similar patterns of expression in all settings: positive nuclear staining of the invading HSC-3 islands with
Twist (most nuclei) and diffuse cytoplasmic staining with CK. In addition, delicate, spindle-shaped cells that closely surround these invading tumor
islands in a concentric pattern are αSMA-positive.
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environment and that factors secreted from the HSC-3
cells can have autocrine and/or paracrine effects. These
findings are reflected by the evolvement of the spindle
cells at the periphery of the HSC-3 tumor islands. Nor-
moxic and hypoxic IM sections showed a similar set of
results.
The other triple immunostaining series aimed to show
that HSC-3 cells (cytokeratin-positive) may undergo
EMT (Twist-positive) and be a source for CAF-like cells
(αSMA+) (Figure 3). Invading cytokeratin-positive HSC-
3 clusters of cells were usually also Twist-positive in
normoxic RM sections. A part of these clusters was sur-
rounded at their periphery by layers of fine cells with
spindle-shaped morphology of an αSMA-positive pheno-
type. Similar findings were present in hypoxic RM sections
and in normoxic and hypoxic IM sections, further
highlighting that hypoxia did not have any effect on the
myoma assay and that the described phenotypical changes
did not depend on the presence of myoma-related media-
tors but rather were self-supplied by the HSC-3 cells.
Since the triple immunostainings revealed similar pat-
terns of expression in both RM and IM assays in nor-
moxic and hypoxic conditions, co-culture studies were
performed only on the IM in normoxic conditions.Co-cultures
We used a cell line of fibroblasts obtained from the
vicinity of a tongue SCC, i.e., CaDEC12 cells, because
CAF cell lines are not yet available. Having been exposed
to carcinoma cells and associated TME, these fibroblasts
assumedly had undergone a “priming” process towards
trans-differentiation into CAFs. This was reflected by
the ubiquitous expression of PDGFR in the CaDEC12
cells, as PDGFR is one of the known markers that are
expressed in the activation state of stromal fibroblasts of
solid tumors while gaining a CAF phenotype [24].
CAV1 immunoreaction in the HSC-3-CaDEC12 cocul-
tures was low (a score of 1) in the upper region of the
myoma in the spindle-shaped, the peri-HSC-3 cells as
well as in the HSC-3 cells. The peri-HSC-3 cells in the
lower region of the myoma showed a high immunoexpres-
sion (a score of 4), whereas the HSC-3 cells demonstrated
a low expression (a score of 1) (Figure 4, Table 1).
These findings may suggest that a substantial part of
the CAV1 is transported from the HSC-3 cells into the
spindle cells in the lower region. The expression of
CAV1 in the HSC-3-GF co-cultures seemed to be simi-
lar in both spindle cells and HSC-3 cells, irrespective of
the myoma region. These findings differed from those
of the HSC-3-CaDEC12 co-cultures and could be
Figure 4 HSC-3 co-cultures: intact myoma, normoxia. HSC-3 cells were cocultured with gingival fibroblasts (GFs) or with fibroblasts isolated
from a human tongue tumor (called CaDEC12 cells). A few caveolin-1-positive cells are seen in the upper region tumor cells (a, d). Caveolin-1-positive
cells are spindle-shaped and concentrically arranged around the invading tumor islands in the lower regions (b, e). Serial sections of d & e (g & h,
respectively) of the lower region also show peri-HSC-3 spindle cells positive for alpha-smooth muscle actin (αSMA). Double immunostaining with
pan-cytokeratin (AE1/AE3, grey color) and caveolin-1 (brown color) in co-cultures of HSC-3 + GF (c) and HSC-3 + CaDEC12 (f) shows that the
spindle-shaped cells surrounding the invading tumor islands are only caveolin-1-positive (black arrows). Some of the cells within the tumor islands are
positive for both cytokeratin and caveolin-1 (c, f, red arrows).
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their crosstalk with the HSC-3 cells. The results of the
control HSC-3 monocultures were similar to those of
the HSC-3-CaDEC12 cocultures, raising the possibility
that introduction of normal GFs could have an effect
on the expression of CAV1 within the HSC-3 cells and
on its distribution to the surrounding cells within the
myoma. Collectively, we suggest that, similarly to other
types of carcinomas (e.g., breast, kidney and colon)
[13], CAV1 accumulates within the CAFs in tongue
cancer as well.
αSMA-positively stained cells were seen in a peri-
HSC-3 location, surrounding tumor islands/clusters in
the lower region. Serial sections clearly demonstrated
that spindle-shaped cells were positively stained for both
CAV1 and αSMA.Table 1 Scores of caveolin-1 expression in normoxic
intact myoma in mono- and co-cultures
Peri-HSC-3
spindle cells
HSC-3
Mono- and co-cultures Upper
regionb
Lower
regionc
Upper
regionb
Lower
regionc
Myoma + HSC-3 + CaDEC12 1 4 1 1
Myoma + HSC-3 + GFa 3 3 3 3
Myoma + HSC-3 1 4 1 1
aGingival fibroblast; bregion immediately adjacent to the overlying HSC-3 cells;
cdeep region within the myoma tissue containing invading HSC-3 islands/clusters.Double immunostaining with pan-cytokeratin and
CAV1 showed that the spindle-shaped cells surrounding
clusters of invading tumor islands/clusters were positive
for CAV1 and not for cytokeratin, thus highlighting the
possibility that the GFs or CaDEC12 cells could serve as
a source for the spindle-shaped cells. Cells within the in-
vading tumor islands/clusters were occasionally positive
for both cytokeratin and CAV1.
In line with the above-described co-localization of
CAV1 and αSMA in CAF-like cells, it has been ele-
gantly shown that CAV1 promotes αSMA expression
in fibroblasts (i.e., CAFs) and that CAV1-positive CAFs
are potentiated to exert force-dependent contraction of
the surrounding matrix in a Rho/Rho kinase-dependent
manner [13]. As a result, the matrix collagen fibers
undergo remodeling by being aligned in a parallel manner,
thus creating directional invasion tracks for the migrating
tumor cells [13,25].
We performed an additional set of experiments on
HSC-3 monolayers since we were interested in exploring
the possibility that the autocrine and paracrine effects of
CAV1 were, at least in part, carried out by its using the
exosomal transport route.
HSC-3 monolayers
This is the first report to show that tongue cancer cells
use exosomes for transferring CAV1 to the TME and
that these exosomes are apparently ingested by different
types of cells within the TME, such as CAFs.
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CAV1 expression in cell extracts
First, we investigated CAV1 expression in HSC-3 cell ex-
tracts in normoxia as well as in hypoxic (1%O2) and
hypoxia-mimicking (CoCl2) conditions, similarly to what
had been investigated in the myoma model. Western blot-
ting for CAV1 detected a corresponding 21 kDa band in
normoxia and bands of a similar width in the hypoxic con-
ditions. This highlights the ability of HSC-3 cells to ex-
press CAV1 and demonstrates that this ability was not
influenced by hypoxia (Figure 5A). In addition, Western
blotting for CAV1 performed on the media of the mono-
layer cells was negative (data not shown).
Since we found no difference in the CAV1 level among
HSC-3 cell extracts from various oxidative conditions, we
proceeded to the isolation of exosomes that had been per-
formed from the media of only the normoxic monolayers.HSC-3 monolayer media exosomes – CAV1
Similar to what we had shown in the cell extracts,
Western blotting performed on Exoquick-isolatedFigure 5 Caveolin-1 in monolayer HSC-3 extracts (A) and in exosome
strong monomeric bands (~21 kDa) (and in complex forms, ~50 kDa – 60
normoxic (NOR) conditions. Hypoxic (HYP) oxidative conditions and hypoxi
from the media of HSC-3 normoxic monolayer submitted to Western blott
complex forms, ~50 kDa – 60 kDa). C. Results of ELISA tests performed on
expression. The results are presented as the mean amount (±SD) of each p
performed on HSC-3 exosomes shows the expression of the exosomal mar
amount (±SD) of each protein, with and without APMA induction. E. Immu
media-isolated exosomes features round-shaped, membrane-bound nanopexosomes clearly showed a band of corresponding
weight to that of CAV1 (Figure 5B).
HSC-3 Exosomes - ELISA and immunoEM Exoquick-
isolated exosomes studied by ELISA also demonstrated
CAV1 expression in these exosomes (Figure 5C), in paral-
lel to the presence of all three known exosomal markers,
CD63, CD9 and CD81 [7] (Figure 5D). The expression of
the examined proteins was generally enhanced by APMA,
implying that the exosomes were restrained within the
cytoplasmic compartment of the HSC-3 cells grown in
monolayers in the absence of adequate stimuli. These
findings differ from those of the HSC-3 cells that were
monocultured on the myoma model, where most of the
CAV1 expression was observed in the TME-like myoma ra-
ther than in the HSC-3 cells, suggesting that CAV1 accu-
mulation within the TME was controlled by different cell-
environment relationships. ImmunoEM nicely showed
round-shaped, membrane-bound nanovesicles, ~150 nm
in diameter, and positive for intra-vesicular CAV1
(Figure 5D). Furthermore, these nano-vesicles showed
positivity to CD63, a classic exosomal marker (Figure 5E).s isolated from their media (B-D). A. Caveolin-1 protein are seen as
kDa) in whole HSC-3 cell extracts cultured in monolayers under
a mimicking CoCl2 media yield similar results. B. Exosomes isolated
ing for caveolin-1 show strong bands in the 20–23 kDa form (and in
the exosomes isolated from HSC-3 monolayer media reveal caveolin-1
rotein of experiments with and without APMA induction. D. ELISA
kers, CD63, CD9 and CD81. The results are presented as the mean
no-electron microscopy that was performed on the monolayer
articles that contain dots positive for both caveolin-1 and CD63.
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noEM controls (data not shown).
Discussion
The contribution of CAV1 to cancer progression,
whether expressed in the cancer cells or in the TME
components, seems to be complex and controversial and
apparently tumor-related as well. Studies on the expres-
sion of CAV1 in both cell lines and human samples of
oral cancer were recently reviewed [26]. Some studies
reported that the expression of CAV1 increased in a
stepwise manner following carcinogenesis, while others
claimed that it was inactivation of CAV1 that played a
role in oral cancer. Expression of CAV1 in the TME of
oral cancer has not been previously examined. We were
the first to show that expression of CAV1 in human
TSCC in the TME components was higher than in the
tumor cells and that it had a negative impact on the
clinical outcomes. Using the 3D myoma organotypic
model for the in vitro studies had the advantage of a nat-
ural hypoxic environment. We found CAV1 expression
to be higher in the TME-like myoma environment com-
pared to the cultured cancer cells, similar to the TSCC
samples, even when severe hypoxic conditions were fur-
ther induced in the myoma assays.
Our clinical findings were not in agreement with those
reported from breast and prostate cancer patients, where
the absence of CAV1 in the TME was associated with
advanced stage, recurrent disease, metastatic spread and
poor survival [27,28]. Furthermore, findings from our
in vitro myoma model contrasted those from investiga-
tions of other types of carcinoma cell lines that were cul-
tured on traditional collagen assays, especially of gastric
[29] and breast [30-32] origins. Those latter studies
showed that breast cancer cells were able to induce oxi-
dative stress (via a yet unknown mechanism) and/or
hypoxic conditions (via HIF-α) in CAFs, which, in turn,
activated autophagic and lysosomal degradation of
CAV1 as well as of dysfunctional mitochondria. The
resulting aerobic glycosylation in CAFs generated oxida-
tive metabolic products, such as lactate, that were used
as nutrients by the cancer cells. The oxidative stress
within the CAFs was also associated with advanced gen-
etic instability in the cancer cells and, hence, an in-
creased biological aggressive behavior. According to this
model, it would be expected that the presence of CAFs
will be inversely related to the expression of CAV1. Con-
trarily, our clinical results showed a significant correl-
ation between the presence of CAFs and CAV1, a
finding which can not be explained by the CAV1 au-
tophagy theory. Furthermore, our in vitro results showed
concomitant expression of CAV1 in αSMA + −CAF-like
cells. Similar to our results, Goetz et al., who studied
breast carcinoma, concluded that CAV1 expression inthe CAFs of breast cancer correlated with low survival,
and that CAV1 expression in fibroblasts favored direc-
tional migration and invasiveness of carcinoma cells
in vitro [13].
In addition to autophagy that delivers cytosolic com-
ponents and organelles, extracellular material and
plasma membrane proteins are delivered to the lyso-
somes via endocytosis and multivesicular bodies (MVBs)
[7,33]. Alternatively, in order to alleviate cellular stress,
MVBs are directed to release their content of unwanted/
damaged materials into the extracellular environment as
exosomes. It can be assumed that when CAV1 is “un-
wanted”, it is removed by the endocytic-MVB-exosomal
route rather than by the autophagy pathway, by virtue of
its membranous location. The balance between exosome
release and autophagy induction is probably regulated by
the cellular metabolic state, but this is still not fully
understood. Several assays showed that cellular stress,
such as thermal or oxidative stress, enhanced the release
of exosomes [34]. Furthermore, it has been shown that
exosomes that were released under oxidative stress pro-
vided recipient cells with resistance to oxidative stress
and with improved survival [35].
Conclusions
Specific exosomal transport of CAV1 has been shown in
only a few systems thus far, and it included exosomes in
the plasma of melanoma patients [36] and in the vesicu-
lar organelles (prostasomes) secreted by human prostate
cancer cells [37]. One of the ways that can enable the ac-
cumulation of CAV1 in the TME is its being secreted by
exosomes. As such, exosomal CAV1 can be present in
the extracellular matrix or it may be ingested by cells
that undergo EMT, by CAFs or by other types of cells.
In the context of oral cancer, the role of CAV1 in the
process of EMT and/or in fibroblast-to-CAF trans-
differentiation should be elucidated in further studies.
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